These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38253803)

  • 1. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients.
    Osipov A; Nikolic O; Gertych A; Parker S; Hendifar A; Singh P; Filippova D; Dagliyan G; Ferrone CR; Zheng L; Moore JH; Tourtellotte W; Van Eyk JE; Theodorescu D
    Nat Cancer; 2024 Feb; 5(2):299-314. PubMed ID: 38253803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in artificial intelligence for pancreatic ductal adenocarcinoma.
    Hayashi H; Uemura N; Matsumura K; Zhao L; Sato H; Shiraishi Y; Yamashita YI; Baba H
    World J Gastroenterol; 2021 Nov; 27(43):7480-7496. PubMed ID: 34887644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.
    Qian ZR; Rubinson DA; Nowak JA; Morales-Oyarvide V; Dunne RF; Kozak MM; Welch MW; Brais LK; Da Silva A; Li T; Li W; Masuda A; Yang J; Shi Y; Gu M; Masugi Y; Bui J; Zellers CL; Yuan C; Babic A; Khalaf N; Aguirre A; Ng K; Miksad RA; Bullock AJ; Chang DT; Tseng JF; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Thorner AR; Ducar M; Wollison B; Laing A; Hahn WC; Meyerson M; Fuchs CS; Ogino S; Hornick JL; Hezel AF; Koong AC; Wolpin BM
    JAMA Oncol; 2018 Mar; 4(3):e173420. PubMed ID: 29098284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning of Histopathological Images Predicts Recurrences of Resected Pancreatic Ductal Adenocarcinoma With Adjuvant Treatment.
    Yamaguchi R; Morikawa H; Akatsuka J; Numata Y; Noguchi A; Kokumai T; Ishida M; Mizuma M; Nakagawa K; Unno M; Miyake A; Tamiya G; Yamamoto Y; Furukawa T
    Pancreas; 2024 Feb; 53(2):e199-e204. PubMed ID: 38127849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective cohort study.
    Lee KS; Jang JY; Yu YD; Heo JS; Han HS; Yoon YS; Kang CM; Hwang HK; Kang S
    Int J Surg; 2021 Sep; 93():106050. PubMed ID: 34388677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer.
    Bereska JI; Janssen BV; Nio CY; Kop MPM; Kazemier G; Busch OR; Struik F; Marquering HA; Stoker J; Besselink MG; Verpalen IM;
    Eur Radiol Exp; 2024 Feb; 8(1):18. PubMed ID: 38342782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence uses multi-omic data to predict pancreatic cancer outcomes.
    Nat Cancer; 2024 Feb; 5(2):226-227. PubMed ID: 38279059
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
    Nahm CB; Turchini J; Jamieson N; Moon E; Sioson L; Itchins M; Arena J; Colvin E; Howell VM; Pavlakis N; Clarke S; Samra JS; Gill AJ; Mittal A
    Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection.
    Otsuka H; Murakami Y; Uemura K; Kondo N; Nakagawa N; Okada K; Seo S; Takahashi S
    J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):421-428. PubMed ID: 32219999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance comparison between multi-center histopathology datasets of a weakly-supervised deep learning model for pancreatic ductal adenocarcinoma detection.
    Carrillo-Perez F; Ortuno FM; Börjesson A; Rojas I; Herrera LJ
    Cancer Imaging; 2023 Jun; 23(1):66. PubMed ID: 37365659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence to Predict Lymph Node Metastasis at CT in Pancreatic Ductal Adenocarcinoma.
    Bian Y; Zheng Z; Fang X; Jiang H; Zhu M; Yu J; Zhao H; Zhang L; Yao J; Lu L; Lu J; Shao C
    Radiology; 2023 Jan; 306(1):160-169. PubMed ID: 36066369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities.
    Wang Y; Lakoma A; Zogopoulos G
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32967105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.
    Franko J; Krasinskas AM; Nikiforova MN; Zarnescu NO; Lee KK; Hughes SJ; Bartlett DL; Zeh HJ; Moser AJ
    J Gastrointest Surg; 2008 Oct; 12(10):1664-72; discussion 1672-3. PubMed ID: 18677542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Germline Variants in Human DNA Damage Repair Genes and Response to Adjuvant Chemotherapy in Resected Pancreatic Ductal Adenocarcinoma.
    Hu H; Zhu Y; Pu N; Burkhart RA; Burns W; Laheru D; Zheng L; He J; Goggins MG; Yu J
    J Am Coll Surg; 2020 Nov; 231(5):527-535.e14. PubMed ID: 32659497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach.
    Rajesh S; Cox MJ; Runau F
    World J Gastroenterol; 2021 Aug; 27(31):5171-5180. PubMed ID: 34497442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A personalized approach to pancreatic ductal adenocarcinoma and its application in surgical practice.
    Schizas D; Koumpoura A; Galari M; Economopoulou P; Vailas M; Sotiropoulou M; Dimitroulis D; Maroulis I; Felekouras E
    Per Med; 2021 Sep; 18(6):613-627. PubMed ID: 34676789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
    du Rieu MC; Torrisani J; Selves J; Al Saati T; Souque A; Dufresne M; Tsongalis GJ; Suriawinata AA; Carrère N; Buscail L; Cordelier P
    Clin Chem; 2010 Apr; 56(4):603-12. PubMed ID: 20093556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiomics, artificial intelligence, and precision medicine in perinatology.
    Pammi M; Aghaeepour N; Neu J
    Pediatr Res; 2023 Jan; 93(2):308-315. PubMed ID: 35804156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
    Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
    J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.